These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28464835)

  • 1. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
    Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
    BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
    Taylor SA; Mallett S; Miles A; Morris S; Quinn L; Clarke CS; Beare S; Bridgewater J; Goh V; Janes S; Koh DM; Morton A; Navani N; Oliver A; Padhani A; Punwani S; Rockall A; Halligan S
    Health Technol Assess; 2019 Dec; 23(66):1-270. PubMed ID: 31855148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
    Taylor SA; Mallett S; Ball S; Beare S; Bhatnagar G; Bhowmik A; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Lock S; Miles A; Morris S; Morton A; Navani N; Oliver A; O'Shaughnessy T; Padhani AR; Prezzi D; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Russell P; Sidhu HS; Strickland N; Tarver K; Teague J; Halligan S;
    Lancet Respir Med; 2019 Jun; 7(6):523-532. PubMed ID: 31080129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
    Taylor SA; Mallett S; Beare S; Bhatnagar G; Blunt D; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Miles A; Morris S; Morton A; Navani N; O'Donohue J; Oliver A; Padhani AR; Pardoe H; Patel U; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Shahabuddin K; Sidhu HS; Teague J; Thaha MA; Train M; van Ree K; Wijeyekoon S; Halligan S;
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):529-537. PubMed ID: 31080095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
    Miles A; Taylor SA; Evans REC; Halligan S; Beare S; Bridgewater J; Goh V; Janes S; Navani N; Oliver A; Morton A; Rockall A; Clarke CS; Morris S;
    Eur Radiol; 2019 Jul; 29(7):3889-3900. PubMed ID: 30937589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
    Miles A; Evans RE; Halligan S; Beare S; Bridgewater J; Goh V; Janes SM; Navani N; Oliver A; Morton A; Morris S; Rockall A; Taylor SA;
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):537-545. PubMed ID: 32410378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
    Adeleke S; Latifoltojar A; Sidhu H; Galazi M; Shah TT; Clemente J; Davda R; Payne HA; Chouhan MD; Lioumi M; Chua S; Freeman A; Rodriguez-Justo M; Coolen A; Vadgama S; Morris S; Cook GJ; Bomanji J; Arya M; Chowdhury S; Wan S; Haroon A; Ng T; Ahmed HU; Punwani S
    BMC Med Imaging; 2019 Nov; 19(1):90. PubMed ID: 31730466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
    Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
    BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.
    Evans RE; Taylor SA; Beare S; Halligan S; Morton A; Oliver A; Rockall A; Miles A
    Br J Radiol; 2018 Jun; 91(1086):20170731. PubMed ID: 29528257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including
    Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA
    Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
    Evans REC; Taylor SA; Kalasthry J; Sakai NS; Miles A;
    Clin Radiol; 2020 Apr; 75(4):308-315. PubMed ID: 31836179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
    Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
    Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer: A Diagnostic Test Accuracy Study.
    Rockall AG; Li X; Johnson N; Lavdas I; Santhakumaran S; Prevost AT; Punwani S; Goh V; Barwick TD; Bharwani N; Sandhu A; Sidhu H; Plumb A; Burn J; Fagan A; Wengert GJ; Koh DM; Reczko K; Dou Q; Warwick J; Liu X; Messiou C; Tunariu N; Boavida P; Soneji N; Johnston EW; Kelly-Morland C; De Paepe KN; Sokhi H; Wallitt K; Lakhani A; Russell J; Salib M; Vinnicombe S; Haq A; Aboagye EO; Taylor S; Glocker B
    Invest Radiol; 2023 Dec; 58(12):823-831. PubMed ID: 37358356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
    Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
    Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.